Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |